Trial Profile
A Phase IIa trial of TS-01 in patients suffering from acute ischemic stroke
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2019
Price :
$35
*
At a glance
- Drugs TS 01 (Primary)
- Indications Stroke
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 06 Nov 2019 Planned number of patients changed to 200.
- 30 Oct 2019 According to a Thrombolytic Science International media release, 10 patients has been enrolled in this study.
- 06 Sep 2018 According to a Thrombolytic Science media release, this study will be led by Prof. Diederik Dippel, MD, PhD, co-director of the Erasmus MC Stroke Center in Rotterdam, The Netherlands.